Total Neoadjuvant Therapy With FOLFIRINOX in Combination With Losartan Followed by Chemoradiotherapy for Locally Advanced Pancreatic CancerJanet E. Murphy, Theodore S. Hong, Jennifer Y. Wo et al.|JAMA Oncology|2019Cited by 518
Dendritic cell paucity in mismatch repair–proficient colorectal cancer liver metastases limits immune checkpoint blockade efficacyWilliam W. Ho, Rakesh K. Jain, Igor L. Gomes‐Santos et al.|Proceedings of the National Academy of Sciences|2021Cited by 91
Addition of Losartan to FOLFIRINOX and Chemoradiation Reduces Immunosuppression-Associated Genes, Tregs, and FOXP3+ Cancer Cells in Locally Advanced Pancreatic CancerYves Boucher, Rakesh K. Jain, Jessica M. Posada et al.|Clinical Cancer Research|2023Cited by 53
1241 IL-1 blockade prevents cardiac toxicity and improves immunotherapy efficacy in mouse models of pancreatic cancerPatrik L. Andersson, Sampurna Chatterjee, Marie Siwicki et al.|Regular and Young Investigator Award Abstracts|2022Cited by 3